Fresenius | FRE - Operating Expenses

Stock Price
48.99
Daily Change
1.03 2.15%
Monthly
2.73%
Yearly
32.69%
Q1 Forecast
45.82

Fresenius reported EUR4.91B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Akzo Nobel EUR 2.25B 73M Sep/2025
Alcon AG USD 2.28B 67M Sep/2025
AstraZeneca USD 16.69B 5.74B Sep/2025
BASF EUR 13.84B 1.11B Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Beiersdorf EUR 4.37B 143M Jun/2025
DaVita Healthcare Partners USD -571.87M 3.42B Sep/2025
Demant DKK 9.39B 392M Jun/2025
E.ON EUR 15.72B 442M Sep/2025
Essilor EUR 12.02B 308M Jun/2025
Fresenius EUR 4.91B 110M Sep/2025
Fresenius Medical Care EUR 4.43B 73.91M Sep/2025
Getinge SEK 9.99B 2.3B Dec/2024
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 5.76B 203M Sep/2025
GN Store Nord DKK 3.62B 81M Sep/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Philips EUR 3.97B 123M Sep/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
RWE EUR 2.32B 715M Sep/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025